These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15111467)

  • 1. Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease. Recommendation statement from the Canadian Task Force on Preventive Health Care.
    Abramson BL;
    CMAJ; 2004 Apr; 170(9):1388-9. PubMed ID: 15111467
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.
    Mosca L; Manson JE; Sutherland SE; Langer RD; Manolio T; Barrett-Connor E
    Circulation; 1997 Oct; 96(7):2468-82. PubMed ID: 9337227
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care.
    Wathen CN; Feig DS; Feightner JW; Abramson BL; Cheung AM;
    CMAJ; 2004 May; 170(10):1535-7. PubMed ID: 15136543
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.
    Cheung AM; Feig DS; Kapral M; Diaz-Granados N; Dodin S;
    CMAJ; 2004 May; 170(11):1665-7. PubMed ID: 15159360
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone replacement therapy.
    Mascitelli L; Pezzetta F
    Ital Heart J; 2003 Jun; 4(6):423; author reply 423-5. PubMed ID: 12898809
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular disease in women.
    Eaker ED; Chesebro JH; Sacks FM; Wenger NK; Whisnant JP; Winston M
    Circulation; 1993 Oct; 88(4 Pt 1):1999-2009. PubMed ID: 8403349
    [No Abstract]   [Full Text] [Related]  

  • 8. Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2013 Jan; 158(1):47-54. PubMed ID: 23090711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopause and the Heart.
    Nkonde-Price C; Bender JR
    Endocrinol Metab Clin North Am; 2015 Sep; 44(3):559-64. PubMed ID: 26316243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of hormone replacement therapy].
    Fait T
    Vnitr Lek; 2014 Nov; 60(11):942-7. PubMed ID: 25600040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone replacement therapy: the pros].
    Jamin C; Madelenat P
    Gynecol Obstet Fertil; 2008 Jan; 36(1):98-103. PubMed ID: 18248839
    [No Abstract]   [Full Text] [Related]  

  • 12. [Does hormone replacement therapy in menopause have a cardiovascular benefit?].
    Scarabin PY
    Rev Med Interne; 2003 Apr; 24(4):216-7. PubMed ID: 12706776
    [No Abstract]   [Full Text] [Related]  

  • 13. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
    Grimes DA; Lobo RA
    Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease prevention in women and the hormone debate.
    MacPherson KI
    AWHONNS Clin Issues Perinat Womens Health Nurs; 1993; 4(2):244-9. PubMed ID: 8242046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Recommendation Statement.
    Am Fam Physician; 2018 Apr; 97(8):Online. PubMed ID: 29671494
    [No Abstract]   [Full Text] [Related]  

  • 16. Menopausal hormone therapy: currently no evidence for cardiac protection.
    Wenger NK
    Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system].
    Kornacewicz-Jach Z; Czarnecka D; Rynkiewicz A; Kotarski J; Paszkowski T; Pertyński T; Debski R; Wielgoś M
    Kardiol Pol; 2009 Jan; 67(1):72-6. PubMed ID: 19253195
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone therapy update. How to make sense of the new recommendations on postmenopausal hormone therapy.
    Harv Womens Health Watch; 2013 Mar; 20(7):3. PubMed ID: 23862210
    [No Abstract]   [Full Text] [Related]  

  • 19. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What you should know about hormone therapy health risks and benefits.
    Menopause; 2013 Nov; 20(11):e5. PubMed ID: 23921520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.